https://www.selleckchem.com/pr....oducts/butyzamide.ht
ory depression. These results provide further support for a favorable adverse effect profile for MCAM. The amygdala is a key brain structure to study in relation to cannabis use as reflected by its high-density of cannabinoid receptors and functional reactivity to processes relevant to drug use. Previously, we identified a correlation between cannabis use in early adolescence and amygdala hyper-reactivity to angry faces (Spechler et al. 2015). Here, we leveraged the longitudinal aspect of the same dataset (the IMAGEN study) to determ
Like
Comment
Share
